© 2022 WEAA
background_fid (2).jpg
Your Source for Cool Jazz and More THE VOICE OF THE COMMUNITY
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
We Need Your Support! Please make a donation today to keep this community resource on the air. Donate today!

News
Wrap-up of news stories taken from the day's local headlines.

The latest on COVID-19 in Maryland: Vaccines, varients, in-person learning

screen_shot_2021-02-23_at_4.38.14_pm.png

https://www.youtube.com/watch?v=V7AcDPzZmcQ

BALTIMORE, MD (WEAA) On Tuesday, Governor Larry Hogan announced a series of updates regarding COVID-19 in Maryland.

The governor addressed a decline in COVID-19 cases and positivity rates, expanded surveillance of COVID-19 variants, a fourth mass vaccination site and a new executive order regarding the reopening of schools.  

The governor started his annoucements off by saying, “We continue to see significant improvement in all of our key COVID-19 metrics”. 

As of Tuesday morning, the Maryland Department of Health reports 662 new coronavirus cases have been added within 24 hours.

The statewide positivity rate is 3.9 % and COVID-related hospitalizations have dropped to 978.

According to the governor, the number of nursing homes with active COVID cases has dropped by 47%, its lowest level since mid- October. 

 

 

Maryland oficials say, "states have been notified to expect allocations of the single-dose Johnson & Johnson vaccine—which is being made here in Maryland—as early as next week". 

 

 

The governor also announced Maryland has entered into agreements with University of Maryland, Baltimore and Johns Hopkins to more than double the state’s surveillance of coronavirus variants to more than 10% of cases. 

 

 

This will provide the state with one of the strongest surveillance systems in the world.

 

In an effort to safely reopen schools, the governor issued an executive order requiring anyone over the age of 5 to wear a face covering in any area of a school setting. 

 

To view the executive order, click here.